These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2011-004074-28 A prospective, open label, multicenter, partially randomized, safety study of one cycle of Promethera HepaStem in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients 2014-11-04 due-trials
Not reported 2013-001045-14 SAF 001: A long-term safety follow-up study of patients having received infusions of HepaStem. 2017-07-20 due-trials
Ongoing 2014-000650-11 A prospective, open label, multicenter, efficacy and safety study of several infusions of Promethera HepaStem in Urea Cycle Disorders pediatric patients not-yet-due
Trial is outside EEC, and reported results 2015-000988-14 Title: Open, Prospective, Historic-Controlled, Multicenter Study to bad-data
Ongoing 2016-001177-32 Multicenter Phase II Safety and Preliminary Efficacy Study of 2 dose regimens of HepaStem in Patients with Acute on Chronic Liver Failure not-yet-due
Other 2017-003989-27 HepaStem Long-Term Safety Registry : Registry for patients who have been administered HepaStem not-yet-due
Ongoing 2018-004449-18 Multicenter, open-label, safety and tolerability study of ascending doses of HepaStem in patients with cirrhotic and pre-cirrhotic non-alcoholic steato-hepatitis (NASH). not-yet-due